TEVA PHARMACEUTICAL INDUSTRIES LTD
For the period ended Dec 31, 2023. Filed Feb 12, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 12, 2024
TEVA$42.97+0.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Page | |||
|---|---|---|---|
| Introduction and Use of Certain Terms | 1 | ||
| Forward-Looking Statements | 1 | ||
| PART I | |||
| Item 1. | Business | 2 | |
| Item 1A. | Risk Factors | 27 | |
| Item 1B. | Unresolved Staff Comments | 50 | |
| Item 1C. | Cybersecurity | 50 | |
| Item 2. | Properties | 52 | |
| Item 3. | Legal Proceedings | 53 | |
| Item 4. | Mine Safety Disclosures | 53 | |
| PART II | |||
| Item 5. | Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 54 | |
| Item 6. | [Reserved] | 55 | |
| Item 7. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 56 | |
| Item 7A. | Quantitative and Qualitative Disclosures about Market Risk | 84 | |
| Item 8. | Financial Statements and Supplementary Data | 87 | |
| Item 9. | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 177 | |
| Item 9A. | Controls and Procedures | 177 | |
| Item 9B. | Other Information | 178 | |
| Item 9C. | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections (Not Applicable) | 179 | |
| PART III | |||
| Item 10. | Directors, Executive Officers and Corporate Governance | 179 | |
| Item 11. | Executive Compensation | 179 | |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 179 | |
| Item 13. | Certain Relationships and Related Transactions, and Director Independence | 179 | |
| Item 14. | Principal Accounting Fees and Services | 179 | |
| PART IV | |||
| Item 15. | Exhibits, Financial Statement Schedules | 180 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.